Irritable bowel syndrome – an evidence-based approach to diagnosis
dc.contributor.author | Cash, Brooks D. | en_US |
dc.contributor.author | Chey, William D. | en_US |
dc.date.accessioned | 2010-06-01T18:13:49Z | |
dc.date.available | 2010-06-01T18:13:49Z | |
dc.date.issued | 2004-06 | en_US |
dc.identifier.citation | Cash, B. D.; Chey, W. D. (2004). "Irritable bowel syndrome – an evidence-based approach to diagnosis." Alimentary Pharmacology & Therapeutics 19(12): 1235-1245. <http://hdl.handle.net/2027.42/71441> | en_US |
dc.identifier.issn | 0269-2813 | en_US |
dc.identifier.issn | 1365-2036 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/71441 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15191504&dopt=citation | en_US |
dc.format.extent | 340013 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Ltd | en_US |
dc.rights | 2004 Blackwell Publishing Ltd | en_US |
dc.title | Irritable bowel syndrome – an evidence-based approach to diagnosis | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Otolaryngology | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | † Division of Gastroenterology, University of Michigan School of Medicine, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | * Division of Gastroenterology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA | en_US |
dc.identifier.pmid | 15191504 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/71441/1/j.1365-2036.2004.02001.x.pdf | |
dc.identifier.doi | 10.1111/j.1365-2036.2004.02001.x | en_US |
dc.identifier.source | Alimentary Pharmacology & Therapeutics | en_US |
dc.identifier.citedreference | Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997; 112: 2120 – 37. | en_US |
dc.identifier.citedreference | Chey WD, Olden K, Carter E, et al. Utility of the Rome I and Rome II criteria for IBS in US women. Am J Gastroenterol 2002; 97: 2803 – 11. | en_US |
dc.identifier.citedreference | Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990; 99: 409 – 15. | en_US |
dc.identifier.citedreference | Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional GI disorders: prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569 – 80. | en_US |
dc.identifier.citedreference | Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications ? Gastroenterology 2002; 122: 1140 – 56. | en_US |
dc.identifier.citedreference | Azpiroz F, Dapoigny M, Pace F, et al. Nongastrointestinal disorders in the irritable bowel syndrome. Digestion 2000; 62: 66 – 72. | en_US |
dc.identifier.citedreference | Talley NJ, Gabriel SE, Harmsen WS, et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995; 109: 1736 – 41. | en_US |
dc.identifier.citedreference | Goodman C, Cronin K, Gemmen E, et al. In: The Burden of Gastrointestinal Diseases. Bethesda, MD: American Gastroenterological Association, 2001: 2 – 65. | en_US |
dc.identifier.citedreference | Martin R, Barron JJ, Zacker C. Irritable bowel syndrome: toward a cost-effective management approach. Am J Manag Care 2001; 7: S268 – 75. | en_US |
dc.identifier.citedreference | Cash BD, Schoenfeld PS, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002; 97: 2812 – 9. | en_US |
dc.identifier.citedreference | Bossuyt PM, Reitsma JB, Bruns DE, et al. Standards for reporting of diagnostic accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Br Med J 2003; 326: 41 – 4. | en_US |
dc.identifier.citedreference | Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for reporting of diagnostic accuracy. Clin Chem 2003; 49: 1 – 6. | en_US |
dc.identifier.citedreference | Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003; 49: 7 – 18. | en_US |
dc.identifier.citedreference | Manning AP, Thompson WG, Heaton KW, et al. Towards a positive diagnosis of the irritable bowel syndrome. Br Med J 1978; 2: 653 – 4. | en_US |
dc.identifier.citedreference | Thompson WG, Dotewall G, Drossman DA, et al. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989; 2: 92 – 5. | en_US |
dc.identifier.citedreference | Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45: II43 – 7. | en_US |
dc.identifier.citedreference | Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastrenterol 1999; 94: 2803 – 7. | en_US |
dc.identifier.citedreference | Saito YA, Locke GR, Talley NJ, et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 2679 – 81. | en_US |
dc.identifier.citedreference | Thompson WG, Irvine EJ, Pare P, et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002; 47: 225 – 35. | en_US |
dc.identifier.citedreference | Mearin F, Badia X, Balboa A, et al. Irritable bowel syndrome prevalence varies enormously depending upon the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001; 36: 1121 – 2. | en_US |
dc.identifier.citedreference | Brandt LJ, Locke R, Olden K, et al. An evidence based approach to the diagnosis of irritable bowel syndrome in North America. Am J Gastroenterol 2002; 97: S1 – S26. | en_US |
dc.identifier.citedreference | Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108 – 31. | en_US |
dc.identifier.citedreference | Schmulson MW, Chang L. Diagnostic approach to the patient with irritable bowel syndrome. Am J Med 1999; 107: 20S – 6S. | en_US |
dc.identifier.citedreference | Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001; 120: 652 – 68. | en_US |
dc.identifier.citedreference | Tolliver BA, Herrera JL, DiPalma JA. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol 1994; 89: 176 – 8. | en_US |
dc.identifier.citedreference | Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: a case–control study in patients fulfilling the Rome II criteria referred to secondary care. Lancet 2001; 358: 1504 – 8. | en_US |
dc.identifier.citedreference | Hamm LR, Sorrells SC, Harding JP, et al. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria. Am J Gastroenterol 1999; 94: 1279 – 82. | en_US |
dc.identifier.citedreference | Helfand M, Redfern CC. Screening for thyroid disease: an update. Ann Int Med 1998; 129: 144 – 58. | en_US |
dc.identifier.citedreference | Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: 286 – 92. | en_US |
dc.identifier.citedreference | O'Leary C, Wieneke P, Buckley S, et al. Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol 2002; 97: 1463 – 7. | en_US |
dc.identifier.citedreference | Scrimshaw NS, Murray EB. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am J Clin Nutr 1988; 48: 1079 – 159. | en_US |
dc.identifier.citedreference | Bourlioux P, Pochart P. Nutritional and health properties of yogurt. World Rev Nutr Diet 1988; 56: 217 – 58. | en_US |
dc.identifier.citedreference | Vesa TH, Seppo LM, Marteau PR, et al. Role of irritable bowel syndrome in subjective lactose intolerance. Am J Clin Nutr 1998; 67: 710 – 5. | en_US |
dc.identifier.citedreference | Tolliver BA, Jackson MS, Jackson KL, et al. Does lactose maldigestion really play a role in the irritable bowel syndrome ? J Clin Gastroenterol 1996; 23: 15 – 7. | en_US |
dc.identifier.citedreference | Bohmer CJ, Tuynman ARE. The effect of a lactose-restricted diet in patients with a positive lactose tolerance test, earlier diagnosed as irritable bowel syndrome: a 5-year follow-up study. Eur J Gastroenterol Hepatol 2001; 13: 941 – 4. | en_US |
dc.identifier.citedreference | Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 3503 – 6. | en_US |
dc.identifier.citedreference | Pimental M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo controlled study. Am J Gastroenterol 2000; 95: 3503 – 6. | en_US |
dc.identifier.citedreference | Francis CY, Duffy JN, Whorwell PJ, et al. Does routine ultrasound enhance diagnostic accuracy in irritable bowel syndrome ? Am J Gastroenterol 1996; 91: 1348 – 50. | en_US |
dc.identifier.citedreference | Lanng C, Mortensen D, Friis M, et al. Gastrointestinal dysfunction in a community sample of subjects with symptoms of irritable bowel syndrome. Digestion 2003; 67: 14 – 19. | en_US |
dc.identifier.citedreference | MacIntosh DG, Thompson WG, Patel DG, et al. Is rectal biopsy necessary in irritable bowel syndrome ? Am J Gastroenterol 1992; 87: 1407 – 9. | en_US |
dc.identifier.citedreference | Yawn BP, Lydick E, Locke GR, et al. Do published guidelines for evaluation of irritable bowel syndrome reflect practice ? BMC Gastroenterol 2001; 1: 11. | en_US |
dc.identifier.citedreference | Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician–patient interaction. Ann Intern Med 1995; 122: 107 – 12. | en_US |
dc.identifier.citedreference | Harvey RF, Mauad EC, Brown AM. Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet 1987; I: 963 – 5. | en_US |
dc.identifier.citedreference | Fine KD, Seidel RH, Do K. The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endosc 2000; 51: 318 – 26. | en_US |
dc.identifier.citedreference | Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 1999; 116: 1464 – 86. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.